Cover Image
Market Research Report
Product code 
907240

Healthcare BPO

Published: | Global Industry Analysts, Inc. | 397 Pages | Delivery time: 1-2 business days

Price

Back to Top
Healthcare BPO
Published: May 1, 2021
Global Industry Analysts, Inc.
Content info: 397 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Abstract:

Global Healthcare BPO Market to Reach US$449.8 Billion by the Year 2027

Amid the COVID-19 crisis, the global market for Healthcare BPO estimated at US$248.2 Billion in the year 2020, is projected to reach a revised size of US$449.8 Billion by 2027, growing at a CAGR of 8.9% over the analysis period 2020-2027.Provider Service, one of the segments analyzed in the report, is projected to grow at a 10.1% CAGR to reach US$158.6 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Payer Service segment is readjusted to a revised 9.3% CAGR for the next 7-year period. This segment currently accounts for a 18.2% share of the global Healthcare BPO market.

The U.S. Accounts for Over 29.6% of Global Market Size in 2020, While China is Forecast to Grow at a 8.2% CAGR for the Period of 2020-2027

The Healthcare BPO market in the U.S. is estimated at US$73.6 Billion in the year 2020. The country currently accounts for a 29.63% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$77.7 Billion in the year 2027 trailing a CAGR of 8.2% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.4% and 7.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR while Rest of European market (as defined in the study) will reach US$77.7 Billion by the year 2027.

Pharmaceutical Service Segment Corners a 49.1% Share in 2020

In the global Pharmaceutical Service segment, USA, Canada, Japan, China and Europe will drive the 8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$97.9 Billion in the year 2020 will reach a projected size of US$167.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$51.7 Billion by the year 2027.

Select Competitors (Total 61 Featured) -

  • Accenture Plc
  • Boehringer Ingelheim
  • Catalent Pharma Solutions, Inc.
  • Conduent, Inc.
  • Covance, Inc.
  • Charles River Laboratories International, Inc.
  • Cognizant Technology Solutions Corporation
  • EXLService Holdings, Inc.
  • GeBBS Healthcare Solutions, Inc.
  • Genpact Limited
  • HCL Technologies Limited
  • Infosys BPM Limited
  • IQVIA
  • Lonza Group AG
  • PAREXEL International Corp.
  • Syneos Health
  • Tata Consultancy Services Limited
  • Wipro Limited
  • WNS Global Services Ltd.
Table of Contents
Product Code: MCP12285

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Impact of Covid-19 and a Looming Global Recession
    • Outlook
    • Segment Review
  • 2. FOCUS ON SELECT PLAYERS
    • Accenture Plc (Ireland)
    • Boehringer Ingelheim (Germany)
    • Catalent Pharma Solutions, Inc. (USA)
    • Conduent, Inc. (USA)
    • Covance, Inc. (USA)
    • Charles River Laboratories International, Inc. (USA)
    • Cognizant Technology Solutions Corporation (USA)
    • EXLService Holdings, Inc. (USA)
    • GeBBS Healthcare Solutions, Inc. (USA)
    • Genpact Limited (India)
    • HCL Technologies Limited (India)
    • Infosys BPM Limited (India)
    • IQVIA (USA)
    • Lonza Group AG (Switzerland)
    • PAREXEL International Corp. (USA)
    • Syneos Health (USA)
    • Tata Consultancy Services Limited (India)
    • Wipro Limited (India)
    • WNS Global Services Ltd. (India)
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Healthcare Costs to Drive Inclination towards BPO Services
    • EXHIBIT 1: Global Cost of Chronic Diseases (In US$ Billion) for the Years 2018 and 2030
    • EXHIBIT 2: Aging Population Burdens an Already Strained Healthcare System: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • EXHIBIT 3: Per Capita Healthcare Expenditure (in $) by Select Countries for 2018
    • Regulatory Challenges Inflate the Demand for Healthcare BPO
    • ICD-10 Coding Standards and Impending Adoption of ICD-11 Standards: Potential for BPO Providers
    • With Many Benefits of Cloud Computing, "The Cloud" Comes With a Silver Lining for BPO Service Providers Struggling to Remain Cost Competitive in the Era of Value Based Care
    • EXHIBIT 4: Inherent Advantages of Cloud Computing Make "The Cloud" a Game Changer in the Healthcare BPO Industry: Benefits of Cloud Measured in % Efficiency Improvements & Cost Reduction
    • Revenue Cycle Management Outsourcing Maximize Revenue Collection Operations
    • EXHIBIT 5: Global Market for Revenue Cycle Management: Revenues in US$ Billion for the Years 2018, 2020, 2022 and 2024
    • Reimbursement Changes Amplify Demand
    • Rise in Healthcare Industry Consolidation Boosts Growth Opportunities
    • Select M&A Deals Involving Large Healthcare Firms
    • Healthcare BPO Market for Pharma Sector
    • EXHIBIT 6: Global Pharmaceutical R&D Spending (US$ Billion) for the Years 2010 through 2020
    • Patent Cliffs in Pharma Industry Drive Dependence on BPO Providers
    • Major Pharma Drugs Losing Patents in 2019
    • Healthcare Analytics Services Address the Challenge of High Data Volumes
    • Industry Witnesses a Surge in Near Shore Outsourcing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Healthcare BPO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Healthcare BPO by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Healthcare BPO by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Provider Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Provider Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Provider Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Payer Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Payer Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Payer Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Pharmaceutical Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Pharmaceutical Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Pharmaceutical Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • Rise in Healthcare Costs Trigger the Need for Healthcare BPO Services
    • Changing Regulations in the US: Implications for the Payer BPO Market
    • EXHIBIT 7: Rising Healthcare Costs Drive Healthcare Reforms in the US: Per Capita Healthcare Expenditure (in $) for the Period 2014-2019
    • EXHIBIT 8: Health Coverage in the US: Percentage Breakdown of Number of Americans Covered by Source of Health Coverage for the Years 2018 and 2028
    • EXHIBIT 9: Healthcare Reforms Lead to Reduced Uninsured Population: Percentage of Uninsured Population for the Period 2008, 2010, 2012, 2014, 2016 and 2018
    • EXHIBIT 10: Number of Medicare ACOs in the US for the Years 2012 through 2018
    • Market Analytics
    • TABLE 13: USA Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 14: USA Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 15: USA 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 16: Canada Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 17: Canada Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 18: Canada 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 19: Japan Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: Japan Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 21: Japan 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • CHINA
    • Chinese Healthcare Industry on a Growth Trajectory
    • Market Analytics
    • TABLE 22: China Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 23: China Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 24: China 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 25: Europe Current & Future Analysis for Healthcare BPO by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 26: Europe Historic Review for Healthcare BPO by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 27: Europe 15-Year Perspective for Healthcare BPO by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 28: Europe Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 29: Europe Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 30: Europe 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 31: France Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 32: France Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 33: France 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 34: Germany Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Germany Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 36: Germany 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 37: Italy Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Italy Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 39: Italy 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 40: UK Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 41: UK Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 42: UK 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 43: Rest of Europe Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Rest of Europe Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 45: Rest of Europe 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • Indian BPO Industry Revolutionizes Healthcare Sector
    • Market Analytics
    • TABLE 46: Asia-Pacific Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 47: Asia-Pacific Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 48: Asia-Pacific 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 49: Rest of World Current & Future Analysis for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: Rest of World Historic Review for Healthcare BPO by Type - Provider Service, Payer Service and Pharmaceutical Service Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
    • TABLE 51: Rest of World 15-Year Perspective for Healthcare BPO by Type - Percentage Breakdown of Value Sales for Provider Service, Payer Service and Pharmaceutical Service for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 61